Wed. 09/26
Session Corporate Member Symposium / KTS Katharinenhall / 4.00 - 6.00 pm
From bench to bedside – developments to improve patient outcomes
Chairman 1: Peter Rutherford, Baxter Healthcare SA / Chairman 2: Gustav Steinhoff, Rostock, Germany
| 4.00 - 04.30 pm | What drives dialysis development? Ingrid Ledebo (Honoured Corporate Guest speaker) |
|
| 4.30 - 04.50 pm | Is the obvious need for artificial organs a peril or a promise? Joerg Vienken, Fresenius Medical Care |
|
| 4.50 - 05.20 pm | Ventricular Assist Devices (VADs) as a mass therapy: Can we learn from the development of hemodialysis? Ed Leonhard, Columbia University, New York, USA and Heinz Schima, Medical University Vienna, Austria |
|
| 5.20 - 05.40 pm | Citrate in dialysis fluids Gunilla Grundström, Gambro Lundia AB |
|
| 5.40 - 6.00 pm | Meeting patient needs – scientists and doctors working together Peter Rutherford, Baxter Healthcare SA |